Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 241

1.

Obesity and hypertension.

El-Atat F, Aneja A, Mcfarlane S, Sowers J.

Endocrinol Metab Clin North Am. 2003 Dec;32(4):823-54. Review.

PMID:
14711064
2.

Hypertension and obesity.

Aneja A, El-Atat F, McFarlane SI, Sowers JR.

Recent Prog Horm Res. 2004;59:169-205. Review.

PMID:
14749502
3.

Role of adipose tissue for cardiovascular-renal regulation in health and disease.

Engeli S, Sharma AM.

Horm Metab Res. 2000 Nov-Dec;32(11-12):485-99. Review.

PMID:
11246814
4.

Emerging concepts in the pathophysiology and treatment of obesity-associated hypertension.

Engeli S, Sharma AM.

Curr Opin Cardiol. 2002 Jul;17(4):355-9. Review.

PMID:
12151869
5.

Mechanisms of obesity-related hypertension.

Lamounier-Zepter V, Bornstein SR, Ehrhart-Bornstein M.

Horm Metab Res. 2004 Jun;36(6):376-80. Review.

PMID:
15241727
6.

Pathophysiology of obesity hypertension.

Hall JE.

Curr Hypertens Rep. 2000 Apr;2(2):139-47. Review.

PMID:
10981140
7.

Mechanisms of obesity-induced hypertension.

Kotsis V, Stabouli S, Papakatsika S, Rizos Z, Parati G.

Hypertens Res. 2010 May;33(5):386-93. doi: 10.1038/hr.2010.9. Review.

PMID:
20442753
8.

Factors that influence the risk of hypertension in obese individuals.

Coatmellec-Taglioni G, Ribière C.

Curr Opin Nephrol Hypertens. 2003 May;12(3):305-8. Review.

PMID:
12698070
9.

Obesity hypertension.

Rocchini AP.

Am J Hypertens. 2002 Feb;15(2 Pt 2):50S-52S. Review.

PMID:
11866230
10.

Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms.

Hall JE, do Carmo JM, da Silva AA, Wang Z, Hall ME.

Circ Res. 2015 Mar 13;116(6):991-1006. doi: 10.1161/CIRCRESAHA.116.305697. Review.

11.

Obesity hypertension: role of leptin and sympathetic nervous system.

Hall JE, Hildebrandt DA, Kuo J.

Am J Hypertens. 2001 Jun;14(6 Pt 2):103S-115S. Review.

PMID:
11411745
12.

Mineralocorticoid receptor activation in obesity hypertension.

Nagase M, Fujita T.

Hypertens Res. 2009 Aug;32(8):649-57. doi: 10.1038/hr.2009.86. Epub 2009 Jun 12. Review.

PMID:
19521418
13.

Obesity-related hypertension: epidemiology, pathophysiology, treatments, and the contribution of perivascular adipose tissue.

Aghamohammadzadeh R, Heagerty AM.

Ann Med. 2012 Jun;44 Suppl 1:S74-84. doi: 10.3109/07853890.2012.663928. Review.

PMID:
22713152
14.

Hypertension in obese patients: a dysmetabolic hypertension with a possible adipocyte dysfunction mechanism.

Blaj S, Stanciu S, Jurcut C, Ciobîcă L.

Rom J Intern Med. 2003;41(2):103-11. Review.

PMID:
15526495
15.
16.

Neuropeptide Y and alpha-melanocyte-stimulating hormone: interaction in obesity and possible role in the development of hypertension.

Baltatzi M, Hatzitolios A, Tziomalos K, Iliadis F, Zamboulis Ch.

Int J Clin Pract. 2008 Sep;62(9):1432-40. doi: 10.1111/j.1742-1241.2008.01823.x. Review.

PMID:
18793378
17.

[Mechanisms of hypertension in obesity].

López de Fez CM, Gaztelu MT, Rubio T, Castaño A.

An Sist Sanit Navar. 2004 May-Aug;27(2):211-9. Review. Spanish.

PMID:
15381953
18.

New developments in mechanisms of obesity-induced hypertension: role of adipose tissue.

Sharma AM, Engeli S, Pischon T.

Curr Hypertens Rep. 2001 Apr;3(2):152-6. Review.

PMID:
11276398
19.

The renin-angiotensin system and natriuretic peptides in obesity-associated hypertension.

Engeli S, Sharma AM.

J Mol Med (Berl). 2001;79(1):21-9. Review.

PMID:
11327100
20.

Impact of the obesity epidemic on hypertension and renal disease.

Hall JE, Jones DW, Kuo JJ, da Silva A, Tallam LS, Liu J.

Curr Hypertens Rep. 2003 Oct;5(5):386-92. Review.

PMID:
12948431
Items per page

Supplemental Content

Write to the Help Desk